Author: Biyuan Liu1, Zhu Fan1, Zheyi Wang1, Man Li2, Tao Lu1
Affiliation:
1 School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
2 School of Medicine, University of St Andrews, Scotland, UK.
Conference/Journal: Medicine (Baltimore)
Date published: 2020 Jan 1
Other:
Volume ID: 99 , Issue ID: 3 , Pages: e18734 , Special Notes: doi: 10.1097/MD.0000000000018734. , Word Count: 237
Background:
Non-pharmacological treatments (education, exercise, and physical therapy) are remain basic approaches to long-term management of ankylosing spondylitis (AS) patients. As an important part of non-pharmacological treatments, Health Qigong is widely used for AS treatment. We will perform the systematic review to confirm the safety and efficacy of Health Qigong for AS.
Methods:
Systematical search of 6 electronic databases will be done, including English and Chinese, until December 2019. All randomized controlled trials (RCTs) involving Health Qigong in combination with conventional therapy for AS will be included. Study selection, data extraction, and validation were performed independently by 2 reviewers. RevMan (V.5.3) will be used for mata-analysis.
Results:
This systematic review will identify the safety and efficacy of Health Qigong in the treatment of AS and update evidence summaries of Health Qigong. At the end of the treatment, the primary outcome is Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) with a range of 0 to 10,and the secondary outcomes will include functional ability that measured by Bath Ankylosing Spondylitis Functional Index (BASFI), mobility measured by Bath Ankylosing Spondylitis Metrology Index (BASMI), chest expansion, night spinal pain, adverse reactions, laboratory measures such as erythrocyte sedimentation rate (ESR) and C protein response (CRP).
Conclusion:
This study will provide evidence that whether Health Qigong can benefit patients with ankylosing spondylitis by reducing disease activity, alleviating pain to support the application of Health Qigong in the AS treatment.
Registration number:
CRD42019159126.
PMID: 32011452 PMCID: PMC7220104 DOI: 10.1097/MD.0000000000018734